There is growing interest in the role and use of pulmonary artery catheters (PACs) in cardiogenic shock (CS). Observational evidence supports an association between use of PACs and improved survival, and specialty societies increasingly advocate for its use. The PAC is useful for early diagnosis, decisions surrounding escalation of care, and daily management. Despite this, its use in Canada is variable. Registries and trials collecting prospective data mandate invasive hemodynamics, and forthcoming evidence-based treatment strategies are likely to be tailored to hemodynamic phenotypes. Herein, we present the case for the routine use of PACs in the management of CS.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Canadian Journal of Cardiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Trends in utilization and outcomes of pulmonary artery catheterization in heart failure with and without cardiogenic shock.J Card Fail. 2019; 25: 364-371
- Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality.JACC Heart Fail. 2020; 8: 903-913
- Pulmonary artery catheters for adult patients in intensive care.Cochrane Database Syst Rev. 2013; : CD003408
- A pan-Canadian survey of cardiogenic shock management: a report from the Canadian Cardiovascular Research Collaboratory (C3) Cardiogenic Shock Working Group.Can J Cardiol. 2022; 38: 1732-1735
- Cardiogenic shock teams and centres: a contemporary review of multidisciplinary care for cardiogenic shock.ESC Heart Fail. 2021; 8: 988-998
Published online: February 07, 2023
Accepted: February 3, 2023
Received: December 8, 2022
Publication stageIn Press Journal Pre-Proof
See page 3 for disclosure information.
© 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.